Akèy › Neyofibòm Plexifòm › Alabama
Etid klinik pou Neyofibòm Plexifòm nan Alabama
4 etid pou Neyofibòm Plexifòm ap chèche patisipan nan sit nan Alabama.
Vil nan Alabama
Tèks ofisyèl etid la (Anglè)
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
- Childrens of Alabama, Birmingham
Ap rekriteFaz 1
Laj 16 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06502171A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
- University of Alabama at Birmingham, Birmingham
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT06541847Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
- Childrens of Alabama, Birmingham
Ap rekriteFaz 2
Laj 1 a 8 · Tout sèks · Mizajou May 29, 2026 · NCT06188741PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
- University of Alabama at Birmingham, Birmingham
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Dec 4, 2025 · NCT06961565Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.